Alzheon Scientific Advisory Board 2017-01-03T18:32:54+00:00

Scientific Advisory Board

Director, Institute for Neurodegenerative Diseases, University of California, San Francisco, California
Professor of Neurology and Biochemistry, University of California San Francisco, California

  • Recipient of the Nobel Prize in Physiology or Medicine in 1997
  • Recipient of the Albert Lasker Award for Basic Medical Research in 1994
  • Recipient of the United States Presidential National Medal of Science
  • Member of the National Academies of Sciences, Engineering and Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society
  • Foreign member of the Royal Society, London

Stanley B. Prusiner, MD, currently serves as the Director of the Institute for Neurodegenerative Diseases and a Professor of Neurology and Biochemistry at the University of California San Francisco (UCSF).

Dr. Prusiner received the Nobel Prize in Physiology or Medicine in 1997 and the Albert Lasker Award for Basic Medical Research in 1994 for his pioneering work discovering prions, a new class of transmissible proteins that trigger protein misfolding in the brain to cause Creutzfeldt-Jakob disease.  Dr. Prusiner discovered ‘prions’ and the concept of transmissible protein misfolding as the cause of diseases, such as bovine spongiform encephalopathy and Creutzfeldt-Jakob disease in humans.  His seminal discovery that amyloid also exhibits prion-like properties led to the association of prions with other neurodegenerative diseases, including Alzheimer’s and Parkinson’s diseases.

Dr. Prusiner’s contributions to scientific research have received widespread international recognition with the receipt of numerous prestigious awards and prizes, including the United States Presidential National Medal of Science.  He is a member of the National Academies of Sciences, Engineering and Medicine, the American Academy of Arts and Sciences, and the American Philosophical Society, and a foreign member of the Royal Society, London.

Dr. Prusiner received a BA in Chemistry and an MD from the University of Pennsylvania.  He completed his neurology residency training at UCSF following military service as a lieutenant commander in the U.S. Public Health Service at the National Institutes of Health.  He joined the UCSF faculty in 1974.  Dr. Prusiner is the author of more than 500 scientific research and 300 review articles, and editor of 11 books on diseases caused by prions.  He holds 50 issued or allowed United States patents.

Professor of Clinical Neurochemistry, University of Gothenburg, Sweden
Head of Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Gothenburg, Sweden

  • Former researcher at the Medical Research Council (MRC), Sweden

Founder, Aslan Academy Consulting, Cincinnati, Ohio
ITECS Innovative Technology Market Development, New Smyrna Beach, Florida

  • Formerly Scientific Review Officer, Emerging Technologies & Training in Neuroscience, Center for Scientific Review, NIH
  • Past Professor and Director of Research, Department of Neurosurgery, University of Cincinnati

Director of Cleveland Clinic Lou Ruvo Center for Brain Health, Las Vegas, Nevada and Cleveland, Ohio
Professor of Neurotherapeutics and Drug Development in the Neurological Institute, Cleveland Clinic, Cleveland, Ohio

  • Past President of the Behavioral Neurology Society and the American Neuropsychiatric Association

Director of the Alzheimer’s Disease Research Unit at McGill University, Montreal, Canada
Professor of Neurology & Neurosurgery, Psychiatry and Medicine at McGill University, Montreal, Canada

  • Member, Douglas Mental Health University Institute’s Research Center
  • Membre Associé, Institut Universitaire de Gériatrie, Université de Montréal

Co-Director of Management of Aging Services Program, McCormack Graduate School, University of Massachusetts, Boston, Massachusetts

  • Past Secretary of the Massachusetts Executive Office of Elders Affairs
  • Executive Director of Massachusetts Governor’s Commissions

Head of Memory Disorders Unit, University Hospital Motol, Prague, Czech Republic
Associate Professor of Neurology, Charles University, Prague, Czech Republic

  • Vice-chair of the European Federation of Neurological Societies Section on Dementia and Cognitive Neurology
  • Chairman of Section on Cognitive Neurology of the Czech Neurological Society

Chief Scientific Officer, Complexa Therapeutics, Inc., Pittsburgh, Pennsylvania
Chief Medical Officer, Q Therapeutics, Inc., Salt Lake City, UT

  • Faculty member at UCSF, Yale, Penn and Uniformed Service of Health Sciences Medical Schools
  • Past Head of Development and Chief Medical Officer at Endo Pharmaceuticals
  • Past Vice President, Global Clinical Research Operations at Pfizer

Co-Founder, ZettaScience, Inc., Scottsdale, Arizona
Consulting Medical Director, Amarantus Bioscience Holdings, Phoenix, Arizona

  • Founder of Pivotal Research Center in Phoenix, one of the largest medical research centers in the U.S.
  • Principal investigator on nearly 400 clinical trials

Director of Research and Education at the Geriatric Clinic and Head of the Unit of Clinical Trials, Karolinska Hospital, Stockholm, Sweden
Professor and Senior Geriatrician, Karolinska University Hospital, Stockholm, Sweden

  • Leading expert on Alzheimer’s risk factors, early diagnoses and disease prevention
  • Expert/member of advisory boards for industry related to dementia studies
  • Founding member of the European Dementia Prevention Initiative (EDPI)
  • Principal investigator – Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Dementia (FINGER)

Professor and Chair, Department of Neurosciences, University of California, San Diego, California
Executive Director of Down Syndrome Center for Research and Treatment at University of California, San Diego, California

  • Founding Director of the Neuroscience Institute at Stanford University
  • Fellow of the Royal College of Physicians
  • Fellow of the American Association for the Advancement of Science

Director of Memory Disorders Clinic, University of Rochester, Rochester, New York
Professor of Psychiatry, University of Rochester School of Medicine, Rochester, New York

  • Director of Alzheimer’s Disease Care, Research and Education Program at the University of Rochester

Chief Executive Officer of Banner Research and Executive Director of Banner Alzheimer’s Institute, Phoenix, Arizona
Professor of Psychiatry, University of Arizona, Tucson, Arizona

  • Director of Arizona Alzheimer’s Consortium
  • Clinical Director, Neurogenomics Division at the Translational Genomics Research Institute

Medical Director of Premiere Research Institute, Palm Beach Neurology, West Palm Beach, Florida
Clinical Professor of Neurology, Nova Southeastern University, Fort Lauderdale, Florida

  • Past Director of St. Mary’s Hospital Memory Disorders Center

CEO & Chief Scientific Officer, JSS Medical Research, Montreal, Canada
Professor of Surgery and Medicine, McGill University, Montreal, Canada
Director of Surgical Research, Jewish General Hospital, Montreal, Canada

  • Reviewer for over five leading peer reviewed journals

Founder & Director of the Alzheimer Center, VU University Medical Center, Amsterdam, Netherlands
Professor of Cognitive Neurology, VU University Medical Center, Amsterdam, Netherlands
Honorary Professor of Neurology, University College London, London, England

  • Vice President, Deltaplan Dementie
  • Past Scientific Director, Dutch Pearlstring Institute (PSI)
  • Elected member of the Royal Academy of Arts and Sciences in 2011

Senior Vice President & Chief Research Officer, Lifespan Hospital System, Providence, Rhode Island
Professor of Neurology, The Alpert Medical School of Brown University, Providence, Rhode Island

  • Past Director and Early Clinical Leader of novel compounds for Alzheimer’s disease and schizophrenia at Pfizer
  • Senior Associate Editor of “Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association”

Chief, Alzheimer’s Disease Clinical and Research Center, University Hospital Center, Toulouse, France
Chairman of the Department of Internal and Geriatric Medicine, University Hospital Center, Toulouse, France

  • President of the International Association of Gerontology and Aging
  • Chairman of the International Academy on Nutrition and Aging
  • Editor-in-chief of the Journal of Nutrition, Health and Aging

Director, Center for Imaging of Neurodegenerative Diseases, UCSF VA Medical Center, San Francisco, California
Professor of Radiology, University of California, San Francisco, California

  • Principal investigator of the Alzheimer’s Disease Neuroimaging Initiative (ADNI), the largest international observational study of Alzheimer’s disease
  • Former Director of the Center for Imaging of Neurodegenerative Diseases (CIND) at the San Francisco Veterans Affairs Medical Center